Latest News and Press Releases
Want to stay updated on the latest news?
-
Pune, India, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The QKS Group SPARK Matrix™ provides competitive analysis & ranking of the leading S&OP vendors.John Galt Solutions, with its Sales &...
-
VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Xali Gold Corp. (TSXV:XGC) ("Xali Gold” or the “Company”) is pleased to announce that it has filed the National Instrument 43-101 (“NI...
-
SHENZHEN, China, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services...
-
Press releases
-
Virtual Pipeline Market Size, Share, & Trends Analysis Report, By Fuel Type (CNG, LNG, Others), By Application, By Region, and Global Forecasts 2026-2033
-
Based on the Results of a Planned Interim Futility Analysis the Inhaled AAT Trial is Unlikely to Demonstrate a Statistically Significant Benefit in its Primary Endpoint Kamada Continues to Supply...
-
Not For Distribution to United States News Wire Services or Dissemination in United States CALGARY, Alberta, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Cavvy Energy Ltd. (“Cavvy” or the “Company”)...
-
MONTREAL, Dec. 08, 2025 (GLOBE NEWSWIRE) -- OR Royalties Inc. (the “Company” or “OR Royalties”) (OR: TSX & NYSE) is pleased to announce that the Toronto Stock Exchange (the “TSX”) has approved...
-
Trial Design Finalized in Consultation and Alignment with U.S. Food and Drug Administration Study Designed to Establish a New Standard for Adult Pneumococcal Conjugate Vaccines Through Head-to-Head...
-
Ocular intends to submit AXPAXLI New Drug Application (NDA) for wet AMD shortly after year one data from SOL-1, if positive SOL-1 topline data remain on track for 1Q 2026 Ocular plans to leverage...